NAPOLI, CRISTINA
NAPOLI, CRISTINA
Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio'
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy
2016 Mini, E; D’Aurizio, R; Perrone, G; Magi, A; Lapucci, A; Tassi, R; Napoli, C; Picariello, L; Landini, I; Brugia, M; Mazzei, T; Tonelli, F; Nobili, S
Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles
2008 Luceri C, Castagnini C, Bigagli E, Toti S, Landini I, Napoli C, Nobili S, Mini E, Dolara P
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients
2004 Morganti, M; Ciantelli, M; Giglioni, B; Putignano, Al; Nobili, S; Papi, L; Landini, I; Napoli, C; Valanzano, R; Cianchi, F; Boddi, V; Tonelli, F; Cortesini, C; Mazzei, T; Genuardi, M; Mini, E.
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients
2004 Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E.
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients.
2004 Morganti M, Ciantelli M, Giglioni B, Putignano AL, Nobili S, Papi L, Landini I, Napoli C, Valanzano R, Cianchi F, Boddi V, Tonelli F, Cortesini C, Mazzei T, Genuardi M, Mini E
D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy
2016 Tassi, R.; Mini, E.; D'Aurizio, R.; Perrone, G.; Magi, A.; Lapucci, A.; Napoli, C.; Picariello, L.; Brugia, M.; Landini, I.; Mazzei, T.; Tonelli, F.; Nobili, S.
Druggable Targets in Pancreatic Adenocarcinoma
2014 Nobili S; Tassi R; Landini I; Perrone G; Napoli C; Mini E
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
2011 Crea F; Nobili S; Paolicchi E; Perrone G; Napoli C; Landini I; Danesi R; Mini E
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616)
2018 Mini, Enrico; Landini, Ida; Lucarini, Laura; Lapucci, Andrea; Napoli, Cristina; Perrone, Gabriele; Tassi, Renato; Masini, Emanuela; Moroni, Flavio; Nobili, Stefania
Expression of thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) genes by polymerase chain reaction (PCR) in gastric cancer patients (PTS): preliminary results
2000 Napoli C.; Morganti M.; Bruno L.; Nobili S.; Cortesini C.; Mazzei T.; Mini E
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy
2016 Tassi, R; Mini, E; D'Aurizio, R; Perrone, G; Magi, A; Lapucci, A; Napoli, C; Picariello, L; Brugia, M; Landini, I; Mazzei, T; Tonelli, F; Nobili, S
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer
2008 Napoli C, Nobili S, Morganti M, Landini I, Cianchi F, Valanzano R, Tonelli F, Mazzei T, Mini E
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer
2009 Mini E; Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Mazzei T.
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma
2014 Nobili S; Napoli C; Puccini B; Landini I; Perrone G; Brugia M; Benelli G; Doria M; Martelli M; Finolezzi E; Di Rocco A; Del Fava E; Rigacci L; Di Lollo S; Bosi A; Mini E.
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer
2011 Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Cortesini C; Mazzei T; Mini E
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles
2008 Landini I, Napoli C, Nobili S, Morganti M, Rigacci L, Bosi A, Mini E
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles
2008 Landini I; Napoli C; Nobili S; Morganti M; Rigacci L; Bosi A; Mini E
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies
2018 Rondy M.; Kissling E.; Emborg H.-D.; Gherasim A.; Pebody R.; Trebbien R.; Pozo F.; Larrauri A.; McMenamin J.; Valenciano M.; Kaic B.; Filipovic S.K.; Visekruna-Vucina V.; Novosel I.P.; Lovric Z.; Petrovic G.; Krause T.G.; Fische T.K.; Lina B.; Falchi A.; Vilcu A.-M.; Souty C.; Blanchon T.; van der Werf S.; Enouf V.; Behillil S.; Valette M.; Bernard-Stoecklin S.; Levy-Bruhl D.; Launay O.; Loulergue P.; Lenzi N.; Lesieur Z.; L'Honneur A.-S.; Galtier F.; Agostini C.; Serrand C.; Merle C.; Foulongne V.; Vanhems P.; Laine F.; Lagathu G.; Carrat F.; Buda S.; Preuss U.; Prahm K.; Schweiger B.; Wedde M.; Heider A.; Martin M.; Biere B.; Duerrwald R.; Domegan L.; Coughlan L.; O'Donnell J.; Joyce M.; Collins C.; Dunford L.; Moran J.; Tuite G.; Duffy M.; Connell J.; de Gascun C.; Rizzo C.; Bella A.; Alfonsi V.; Castrucci M.R.; Puzelli S.; Pagani E.; Ghisetti V.; Pariani E.; Baldanti F.; Palu G.; D'Agaro P.; Ansaldi F.; Affanni P.; Rossolini G.M.; Camilloni B.; Bagnarelli P.; Sanguinetti M.; Atripaldi L.; Chironna M.; Serra C.; Vitale F.; Chironna M.; Germinario C.; Orsi A.; Manini I.; Montomoli E.; Napoli C.; Orsi G.B.; Casado I.; Castilla J.; Fernandino L.; Martinez-Baz I.; Ezpeleta G.; Navascues A.; Perez-Garcia A.; Aguinaga A.; Ezpeleta C.; Meijer A.; van den Brink S.; van der Hoek W.; Goderski G.; Wijsman L.; Bagheri M.; Dijkstra F.; de Lange M.; Marzec T.; Overduin P.; Teirlinck A.; Wentink E.; Donker G.; Marbus S.; van Gageldonk-Lafeber R.; Schneeberger P.; van Oosterheert J.J.; Schweitzer V.; Groeneveld G.; Nunes B.; Machado A.; Rodrigues A.P.; Gomez V.; Kislaya I.; Guiomar R.; Pechirra P.; Cristovao P.; Costa I.; Panarra A.; Corte-Real R.; Pocas J.; Peres M.J.; Comas L.G.; Marisquerena M.E.I.; Galan J.C.; Folgueira M.D.; Carril F.G.; Martinez R.S.; Cilla G.; Castilla J.; Cenoz M.G.; Rubio C.Q.; Ochoa E.M.; Blasco M.; Duran J.G.; Vanrell J.M.; Reina J.; Castrillejo D.; Gherasim A.M.; Delgado C.; Oliva J.; Casas I.; Garcia M.; Latorre M.; Beamonte A.M.M.; Sapina A.M.; Amores M.O.; Aizpurua A.; Montes M.; Zakikhany K.; Brytting M.; Wiman A.; Carnahan A.; Warburton F.; Djennad A.; Ellis J.; Andrews N.; Marques D.; Cottrell S.; Reynolds A.; Gunson R.; Galiano M.; Lackenby A.; Robertson C.; O'Doherty M.; Sinnathamby M.; Yonova I.; Moore C.; Sartaj M.; de Lusignan S.; Zambon M.; Moren A.; Penttinen P.
Marked variation thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression in human colorectal cancer
1998 Mini E, Biondi C, Morganti M, Napoli C, Mazzoni P, Cianchi F, Rossi S, Tonelli F, Cortesini C, Mazzei T
Molecular analysis of the FHIT gene in human sporadic colon cancers.
1999 Luceri C, De Filippo C, Caderni G, Mini E, Napoli C, Tonelli F, Cortesini C, Dolara P
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy | 2016 | Mini, E; D’Aurizio, R; Perrone, G; Magi, A; Lapucci, A; Tassi, R; Napoli, C; Picariello, L; Landini, I; Brugia, M; Mazzei, T; Tonelli, F; Nobili, S | |
| Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles | 2008 | Luceri C, Castagnini C, Bigagli E, Toti S, Landini I, Napoli C, Nobili S, Mini E, Dolara P | |
| Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients | 2004 | Morganti, M; Ciantelli, M; Giglioni, B; Putignano, Al; Nobili, S; Papi, L; Landini, I; Napoli, C; Valanzano, R; Cianchi, F; Boddi, V; Tonelli, F; Cortesini, C; Mazzei, T; Genuardi, M; Mini, E. | |
| Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients | 2004 | Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E. | |
| Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. | 2004 | Morganti M, Ciantelli M, Giglioni B, Putignano AL, Nobili S, Papi L, Landini I, Napoli C, Valanzano R, Cianchi F, Boddi V, Tonelli F, Cortesini C, Mazzei T, Genuardi M, Mini E | |
| D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy | 2016 | Tassi, R.; Mini, E.; D'Aurizio, R.; Perrone, G.; Magi, A.; Lapucci, A.; Napoli, C.; Picariello, L.; Brugia, M.; Landini, I.; Mazzei, T.; Tonelli, F.; Nobili, S. | |
| Druggable Targets in Pancreatic Adenocarcinoma | 2014 | Nobili S; Tassi R; Landini I; Perrone G; Napoli C; Mini E | |
| Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies | 2011 | Crea F; Nobili S; Paolicchi E; Perrone G; Napoli C; Landini I; Danesi R; Mini E | |
| Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) | 2018 | Mini, Enrico; Landini, Ida; Lucarini, Laura; Lapucci, Andrea; Napoli, Cristina; Perrone, Gabriele; Tassi, Renato; Masini, Emanuela; Moroni, Flavio; Nobili, Stefania | |
| Expression of thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) genes by polymerase chain reaction (PCR) in gastric cancer patients (PTS): preliminary results | 2000 | Napoli C.; Morganti M.; Bruno L.; Nobili S.; Cortesini C.; Mazzei T.; Mini E | |
| Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy | 2016 | Tassi, R; Mini, E; D'Aurizio, R; Perrone, G; Magi, A; Lapucci, A; Napoli, C; Picariello, L; Brugia, M; Landini, I; Mazzei, T; Tonelli, F; Nobili, S | |
| Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer | 2008 | Napoli C, Nobili S, Morganti M, Landini I, Cianchi F, Valanzano R, Tonelli F, Mazzei T, Mini E | |
| Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer | 2009 | Mini E; Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Mazzei T. | |
| Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma | 2014 | Nobili S; Napoli C; Puccini B; Landini I; Perrone G; Brugia M; Benelli G; Doria M; Martelli M; Finolezzi E; Di Rocco A; Del Fava E; Rigacci L; Di Lollo S; Bosi A; Mini E. | |
| Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer | 2011 | Nobili S; Napoli C; Landini I; Morganti M; Cianchi F; Valanzano R; Tonelli F; Cortesini C; Mazzei T; Mini E | |
| In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles | 2008 | Landini I, Napoli C, Nobili S, Morganti M, Rigacci L, Bosi A, Mini E | |
| In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles | 2008 | Landini I; Napoli C; Nobili S; Morganti M; Rigacci L; Bosi A; Mini E | |
| Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies | 2018 | Rondy M.; Kissling E.; Emborg H.-D.; Gherasim A.; Pebody R.; Trebbien R.; Pozo F.; Larrauri A.; McMenamin J.; Valenciano M.; Kaic B.; Filipovic S.K.; Visekruna-Vucina V.; Novosel I.P.; Lovric Z.; Petrovic G.; Krause T.G.; Fische T.K.; Lina B.; Falchi A.; Vilcu A.-M.; Souty C.; Blanchon T.; van der Werf S.; Enouf V.; Behillil S.; Valette M.; Bernard-Stoecklin S.; Levy-Bruhl D.; Launay O.; Loulergue P.; Lenzi N.; Lesieur Z.; L'Honneur A.-S.; Galtier F.; Agostini C.; Serrand C.; Merle C.; Foulongne V.; Vanhems P.; Laine F.; Lagathu G.; Carrat F.; Buda S.; Preuss U.; Prahm K.; Schweiger B.; Wedde M.; Heider A.; Martin M.; Biere B.; Duerrwald R.; Domegan L.; Coughlan L.; O'Donnell J.; Joyce M.; Collins C.; Dunford L.; Moran J.; Tuite G.; Duffy M.; Connell J.; de Gascun C.; Rizzo C.; Bella A.; Alfonsi V.; Castrucci M.R.; Puzelli S.; Pagani E.; Ghisetti V.; Pariani E.; Baldanti F.; Palu G.; D'Agaro P.; Ansaldi F.; Affanni P.; Rossolini G.M.; Camilloni B.; Bagnarelli P.; Sanguinetti M.; Atripaldi L.; Chironna M.; Serra C.; Vitale F.; Chironna M.; Germinario C.; Orsi A.; Manini I.; Montomoli E.; Napoli C.; Orsi G.B.; Casado I.; Castilla J.; Fernandino L.; Martinez-Baz I.; Ezpeleta G.; Navascues A.; Perez-Garcia A.; Aguinaga A.; Ezpeleta C.; Meijer A.; van den Brink S.; van der Hoek W.; Goderski G.; Wijsman L.; Bagheri M.; Dijkstra F.; de Lange M.; Marzec T.; Overduin P.; Teirlinck A.; Wentink E.; Donker G.; Marbus S.; van Gageldonk-Lafeber R.; Schneeberger P.; van Oosterheert J.J.; Schweitzer V.; Groeneveld G.; Nunes B.; Machado A.; Rodrigues A.P.; Gomez V.; Kislaya I.; Guiomar R.; Pechirra P.; Cristovao P.; Costa I.; Panarra A.; Corte-Real R.; Pocas J.; Peres M.J.; Comas L.G.; Marisquerena M.E.I.; Galan J.C.; Folgueira M.D.; Carril F.G.; Martinez R.S.; Cilla G.; Castilla J.; Cenoz M.G.; Rubio C.Q.; Ochoa E.M.; Blasco M.; Duran J.G.; Vanrell J.M.; Reina J.; Castrillejo D.; Gherasim A.M.; Delgado C.; Oliva J.; Casas I.; Garcia M.; Latorre M.; Beamonte A.M.M.; Sapina A.M.; Amores M.O.; Aizpurua A.; Montes M.; Zakikhany K.; Brytting M.; Wiman A.; Carnahan A.; Warburton F.; Djennad A.; Ellis J.; Andrews N.; Marques D.; Cottrell S.; Reynolds A.; Gunson R.; Galiano M.; Lackenby A.; Robertson C.; O'Doherty M.; Sinnathamby M.; Yonova I.; Moore C.; Sartaj M.; de Lusignan S.; Zambon M.; Moren A.; Penttinen P. | |
| Marked variation thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression in human colorectal cancer | 1998 | Mini E, Biondi C, Morganti M, Napoli C, Mazzoni P, Cianchi F, Rossi S, Tonelli F, Cortesini C, Mazzei T | |
| Molecular analysis of the FHIT gene in human sporadic colon cancers. | 1999 | Luceri C, De Filippo C, Caderni G, Mini E, Napoli C, Tonelli F, Cortesini C, Dolara P |